PMDA drug package insert
カボメティクス錠20mg
PMDA Prescription drug · 武田薬品工業株式会社 · package insert Feb 15, 2024
Key facts
| Brand names | カボメティクス錠20mg, カボメティクス錠60mg |
|---|---|
| Nonproprietary names | カボザンチニブリンゴ酸塩 |
| Companies | 製造販売元／武田薬品工業株式会社, 提携／Exelixis, Inc. |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤／キナーゼ阻害剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291064F1020, 4291064F2026 |
| Approval numbers | 30200AMX00433, 30200AMX00434 |
| Package insert edition | 第7版 |
| Package insert date | Feb 15, 2024 |
| PMDA document key | 400256_4291064F1020_1 |
| PMDA company code | 400256 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: